Thymoma and thymic carcinoma

European Journal of Cardio-thoracic Surgery

Volumn 37, Issue 1, 2010, Pages 13-25

  Venuta, Federico ^a   Anile, Marco ^a   Diso, Daniele ^a   Vitolo, Domenico ^a   Rendina, Erino A ^a   De Giacomo, Tiziano ^a   Francioni, Federico ^a   Coloni, Giorgio Furio ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Mediastinal tumours; Myasthenia gravis; Thymic carcinoma; Thymoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; OCTREOTIDE; PREDNISONE; VINCRISTINE;

CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; HUMAN; MEDIASTINUM TUMOR; MYASTHENIA GRAVIS; PRIORITY JOURNAL; REVIEW; THYMOMA; THYMUS CANCER; TUMOR VOLUME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; THYMECTOMY; THYMOMA; THYMUS NEOPLASMS;

EID: 72749124489     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.05.038     Document Type: Review

References (152)

1. Schmidt-Wolf I.G., Rockstroh J.K., Schuller H., Hirner A., Grohe C., Muller-Hermelink H.K., and Huhn D. Malignant thymoma: current status of classification and multimodality treatment. Ann Hematol 82 (2003) 69-76
2. Detterbeck F.C., and Parsons A.M. Thymic tumors. Ann Thorac Surg 77 (2004) 1860-1869
3. Kornstein M. Controversies regarding the pathology of thymoma. Pathol Annu 27 (1991) 1-15
4. Suster S., and Moran C.A. Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma: a clinicopathologic study. Am J Surg Pathol 20 (1996) 1480-1496
5. Snover D.S., Levine G.D., and Rosai J. Thymic carcinoma. Five distinct histological variants. Am J Surg Pathol 6 (1982) 451-470
6. Nakahara K., Ohno K., Hashimoto J., Maeda H., Miyoshi S., Sakurai M., Monden Y., and Kawashima Y. Thymoma: results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg 95 (1988) 1041-1047
7. Lewis J.E., Wick H.R., Scheithauer B.W., Bernatz P.E., and Tayolor W.F. Thymoma: a clinicopathologic review. Cancer 60 (1987) 2727-2743
8. Cowen D., Richaud P., Mornex F., Bachelot T., Jung G.M., Mirabel X., Marchai C., Lagrange J.L., Rambert P., and Chaplain G. Thymoma: results of a multicentric retrospective series of 149 non metastatic irradiated patients and review of the literature. FNCLCC trialists. Federation Nationale des centres de lutte contre le cancer. Radiother Oncol 34 (1995) 9-16
9. Okumura M., Miyoshi S., Takeuchi Y., Yoon H.E., Minami A., Takeda S.I., Fujii Y., Nakahara K., and Matsuda H. Results of surgical treatment of thymomas with special reference to the involved organs. J Thorac Cardiovasc Surg 117 (1999) 605-613
10. Wilkins K.B., Sheikh E., Green R., Patel M., George S., Takano M., Diener-West M., Welsh J., Howard S., Askin F., and Bulkey G.B. Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg 230 (1999) 562-574
11. Blumberg D., Port J.L., Wechsler B., Delgado R., Rosai J., Bains M.S., Ginsberg R.J., Martini N., McCormack P.M., Rusch V., and Burt M.E. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg 60 (1995) 908-914
12. Ogawa K., Uno T., Toita T., Onishi H., Yoshida H., Kakinohara Y., Adachi G., Itami J., Ito H., and Murajama S. Postoperative radiotherapy for patients with completely resected thymoma. Cancer 94 (2002) 1405-1413
13. Curran Jr. W.J., Kornstein M.J., Brooks J.J., and Turrisi III A.T. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 6 (1988) 1722-1727
14. Myojin M., Choi N.C., Wright C.D., Wain J.C., Harris N., Hug E.B., Mathisen D.J., Lynch T., Carey R.W., Grossbard M., Finkelstein D.M., and Grillo H.C. Stage III thymoma: patterns of failure after surgery and postoperative radiotherapy and its implications for future stuffy. Int J Radiat Oncol Biol Phys 46 (2000) 927-933
15. Souadjian J.V., Enriquez P., Silverstein M.N., and Papin J.M. The spectrum of diseases associated with thymoma. Arch Intern Med 134 (1974) 374-379
16. Rosenow E.C., and Hurley B.T. Disorders of the thymus. Arch Intern Med 144 (1984) 763-770
17. Regnard J.F., Magdeleinat P., Dromer C., Dulmet E., De Montpreville V., Levi J.F., and Levasseur P. Prognostic factors and long term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 112 (1996) 376-384
18. Maggi G., Casadio C., Cavallo A., Cianci R., Molinatti M., and Ruffini E. Thymoma: results of 241 operated cases. Ann Thorac Surg 51 (1991) 152-156
19. Morgenthaler T.I., Brown L.R., Colby T.V., Harper Jr. C.M., and Coles D.T. Thymoma. Mayo Clin Proc 68 (1993) 1110-1123
20. Barnes E.W., and Irvine W.J. Clinical syndromes associated with thymic disorders. Proc R Soc Med 66 (1973) 151-154
21. Souza C.A., and Muller N.L. Imaging of the mediastinum. In: Patterson G.A., Cooper J.D., Deslauriers J., Lerut A.E.M.R., Luketich J.D., and Rice T.W. (Eds). Pearson's thoracic and oesophageal surgery. 3rd edition (2008), Churchill Livingstone 1477-1505
22. Jung K.J., Lee K.S., Han J., Kim J., Kim T.S., and Kim E.A. Malignant thymic epithelial tumors. Am J Roentgenol 176 (2001) 433-439
23. LeBlanc J., and Wood D.E. Diagnosis of mediastinal tumors. In: Wood D.E., and Thomas C.R. (Eds). Mediastinal tumors: update 1995, medical radiology. Diagnostic imaging and radiation oncology volume (1995), Springer-Verlag, Heidelberg, Germany 1-10
24. Tomiyama N., Johkoh T., Mihara N., Honda O., Kozuka T., Koyama M., Hamada S., Okumura M., Ohta M., Eimoto T., Miyagawa M., Muller N.L., Ikezoe J., and Nakamuta H. Using the World Health Organization classification of thymic epithelial neoplasms to describe CT findings. Am J Roentgenol 179 (2002) 881-886
25. Puri V., and Meyers B.F. Utility of positron emission tomography in the mediastinum: moving beyond lung and esophageal cancer staging. Thorac Surg Clin 19 (2009) 7-15
26. Liu R.S., Yeh S.H., Huang M.H., Wang L.S., Chu L.S., Chang C.P., Chy Y.K., and Wu L.C. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report. Eur J Nucl Med 22 (1995) 1402-1407
27. El-Bawab H., Al-Sugair A.A., Rafay M., Hajjar W., Mahdy M., and Al-Kattan K. Role of fluorine-18 fluorodeoxyglucose positron emission tomography in thymic pathology. Eur J Cardiothorac Surg 31 (2007) 731-736
28. Masaoka A., Monden Y., Nakahara K., and Tanioke T. Follow up study of thymomas with special reference to their clinical stages. Cancer 48 (1981) 2485-2492
29. Gamondes J.P., Balawi A., Greenland T., Adleine P., Mornex G.F., Zhang J., and Maret G. Seventeen years of surgical treatment of thymoma: factors influencing survival. Eur J Cardiothorac Surg 5 (1991) 124-131
30. Yamakawa Y., Masaoka A., Hashimoto T., Niwa H., Mizuno T., Fujii Y., and Nakahara K. A tentative tumor-node metastasis classification of thymoma. Cancer 68 (1991) 1984-1987
31. International Union Against Cancer. TNM supplement. A commentary on uniform use. 3rd edition (2003), Wiley-Liss, New York
32. Koga K., Matsuno Y., Noguchi M., Mukai K., Asamura H., Goya T., and Shimosato Y. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non invasive thymoma. Pathol Int 44 (1994) 359-367
33. Kondo K., and Monden Y. Lymphogenous and haematogenous metastasis of thymic epithelial tumors. Ann Thorac Surg 76 (2003) 1859-1865
34. Pescarmona E., Rendina E.A., Venuta F., Ricci C., Ruco L.P., and Baroni C.D. The prognostic implication of thymoma histologic subtyping. A study of 80 consecutive cases. Am J Clin Pathol 93 (1990) 190-195
35. Verley J.M., and Hallman K.H. Thymoma: a comparative study of clinical stages, histologic features and survival in 200 cases. Cancer 55 (1985) 1074-1086
36. Ruffini E., Mancuso M., Oliaro A., Casadio C., Cavallo A., Cianci R., Filosso P.L., Molinatti M., Porrello C., Cappello N., and Maggi G. Recurrence of thymoma: analysis of clinicopathological features, treatment and outcome. J Thorac Cardiovasc Surg 113 (1997) 55-63
37. Okumura M., Ohta M., Tateyama H., Nakagawa K., Matsumura A., Maeda H., Tada H., Eimoto T., Matsuda H., and Masaoka A. The World Organization histologic classification system reflects the oncologic behaviour of thymoma: a clinical study of 273 patients. Cancer 94 (2002) 624-632
38. Lopez-Cano M., Ponseti-Bosh J.M., Espin-Bosany E., Sanchez-Garcia J.L., and Armongol-Canosco M. Clinical and pathologic predictors of outcome in thymoma associated myasthenia gravis. Ann Thorac Surg 76 (2003) 1643-1649
39. Nagakawa K., Asamura H., Matsumo Y., Suzuki K., Kondo H., Maeshima A., Miyaoka E., and Tsushia R. Thymoma: a clinicopathological study based on a new World Health Organization classification. J Thorac Cardiovasc Surg 126 (2003) 1134-1140
40. Monden Y., Nakahara K., Lioka S., Nanjo S., Ohno K., Fujii Y., Hashimoto J., Kitagawa Y., Masaoka A., and Kawashima Y. Recurrent thymoma: clinicopathological features, therapy and prognosis. Ann Thorac Surg 39 (1985) 165-169
41. Pescarmona E., Rendina E.A., Venuta F., D'Arcangelo E., Pagani M., Ricci C., Ruco L.P., and Baroni C.D. Analysis of prognostic factors and clinicopathological staging of thymoma. Ann Thorac Surg 50 (1990) 534-538
42. Strobel P., Bauer A., Puppe B., Kraushaar T., Krein A., Toyka K., Semik M., Kiefer R., Nix W., Schalke B., Muller-Hermelink H.K., and Marx A. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol 22 (2004) 1501-1509
43. Pan C.C., Wun H.P., Yang C.F., Chen W.Y., and Chiang H. The clinicopathological correlation of epithelial subtyping in thymoma: a study of 112 consecutive cases. Hum Pathol 25 (1994) 893-899
44. Chalabreysse L., Roy P., Cordier J.F., Loire R., Gamondes J.P., and Thivolet-Bejui F. Correlation of the WHO schema for the classification of thymic neoplasms with prognosis. Am J Surg Pathol 26 (2002) 1605-1611
45. Quintanilla-Martinez L., Wilkins Jr. E.W., Choi N., Efid J., and Harris N. Thymoma: histologic classification is an independent prognostic factor. Cancer 74 (1994) 606-617
46. Lardenois D., Rechsteiner R., Lang R.H., Gugger M., Betticher D., von Briel C., Krueger T., and Ris H.B. Prognostic relevance of Masaoka and Muller-Hermelink classification in patients with thymic tumors. Ann Thorac Surg 69 (2000) 1550-1555
47. Kondo K., Yoshizawa K., Tsuyuguchi M., Kimura S., Sumitomo M., Morita J., Myioshi T., Sakiyama S., Mukai K., and Monden Y. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg 77 (2004) 1183-1188
48. Park M.S., Chung K.Y., Kim K.D., Yang W.Y., Chung J.H., Kim Y.S., Chang J., Kim J.K., Kim S.K., and Kim S.K. Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification. Ann Thorac Surg 78 (2004) 992-997
49. Chen G., Marx A., Wen - Hu C., Yong J., Puppe B., Stroebel P., and Muller-Hermelink H.K. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer 95 (2002) 420-429
50. Kirchner T., Marino M., and Muller-Hermelink H.K. New approaches to the diagnosis of thymic epithelial tumors. Prog Surg Pathol 10 (1989) 167-189
51. Rosai J., and Sobin L. Histological typing of tumors of the thymus. In: Rosai J., and Sobin L. (Eds). World Health organization, International classification of tumors (1999), Sprinter, Berlin 9-14
52. Kondo K., and Monden Y. Therapy of thymic epithelial tumors: a clinical study of 1320 patients from Japan. Ann Thorac Surg 75 (2003) 878-885
53. Venuta F., Rendina E.A., Pescarmona E., De Giacomo T., Vegna M.L., Fazi P., Flaishman I., Guarino E., and Ricci C. Multimodality treatment of thymoma: a prospective study. Ann Thorac Surg 64 (1997) 1585-1592
54. Venuta F., Rendina E.A., Longo F., De Giacomo T., Anile M., Mercadante E., Ventura L., Osti M.F., Francioni F., and Coloni G.F. Long term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg 76 (2003) 1866-1872
55. Schneider P.M., Fellbaumc C., Fink U., Bollschweiler E., and Prauer H.W. Prognostic importance of histomorphologic subclassification for epithelial thymic tumors. Ann Surg Oncol 4 (1997) 46-56
56. Muller-Hermelink H.K., and Marx A. Pathological aspects of malignant and benign thymic disorders. Ann Med 31 (1999) 5-14
57. Suster S., and Rosai J. Thymic carcinoma: a clinicopathologic study of 60 cases. Cancer 67 (1991) 1025-1032
58. Kirchner T., Schalke B., Buchwald J., Ritter M., Marx A., and Muller-Hermelink H.K. Well differentiated thymic carcinoma: an organotypical low-grade carcinoma with relationships to cortical thymoma. Am J Surg Pathol 16 (1992) 1153-1169
59. Blumberg D., Burt M.E., Bains M.S., Downey R.J., Martini N., Rush V., and Ginsbergh R.J. Thymic carcinoma: current staging does not predict prognosis. J Thorac Cardiovasc Surg 115 (1998) 303-309
60. Kuo T.T., and Chan J.K. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile. Am J Surg Pathol 22 (1998) 1474-1482
61. Morinaga S., Sato Y., Shimosato Y., Sinkei T., and Tsuchiya R. Multiple thymic squamous cell carcinomas associated with mixed type thymoma. Am J Surg Pathol 11 (1987) 982-988
62. Pescarmona E., Rendina E.A., Venuta F., Ricci C., and Baroni C.D. Recurrent thymoma: evidence for histological progression. Histopathology 27 (1995) 445-449
63. Muller-Hermelink H.K., Strobel P., and Zetti A. Combined thymic epithelial tumors. In: Travis W.D., Brambilla E., Muller-Hermelink H.K., and Harris C.C. (Eds). Pathology and genetics: tumors of the lung, pleura, thymus and heart (WHO classification of tumors) (2004), IARC Press, Lyon, France 196-201
64. Verghese E.T., den Bakker M.A., Campbell A., Hussein A., Nicholson A.G., Rice A., Corrin B., Rossi D., Langman G., Monaghan H., Gosney J., Seet J., Kerr K., Suvarna S.K., Burke M., Bishop P., Pomplun S., Willemson S., and Addis B. Interobserver variation in the classification of thymic tumors - a multicentre study using the WHO classification system. Histopathology 53 (2008) 218-223
65. Marchevsky A.M., Gupta R., McKenna R.J., Wich M., Moran C., Zakowski M.F., and Suster S. Evidence-based pathology and pathologic evaluation of thymomas. Cancer 112 (2008) 2780-2788
66. Suster S., and Moran C.A. Histologic classification of thymoma: the World Health Organization and beyond. Henatol Oncol Clin North Am 22 (2008) 381-392
67. Jackson M.A., and Ball D.L. Postoperative radiotherapy in invasive thymoma. Radiother Oncol 21 (1991) 77-82
68. Wright C.D., Wain J.C., Wong D.R., Donhaue D.M., Gaissert H.A., Grillo H.C., and Mathisen D.J. Predictors of recurrence in thymic tumors: importance of invasion, World Health Organization histology and size. J Thorac Cardiovasc Surg 130 (2005) 1413-1421
69. Wilkins E.J., Edmunds L.H., and Castleman B. Cases of thymoma at the Massachusset general hospital. J Thorac Cardiovasc Surg 52 (1966) 322-330
70. Moore K.H., Mc Kenzie P.R., Kennedy C.W., and Mc Caughan B.C. Thymoma: trends over time. Ann Thorac Surg 72 (2001) 203-207
71. Kondo K., and Monden Y. Thymoma and myasthenia gravis: a clinical study. Ann Thorac Surg 79 (2005) 219-224
72. Wang L.S., Huang H.H., Lin T.S., Huang B.S., and Chien K.Y. Malignant thymoma. Cancer 70 (1992) 443-450
73. Elert O., Buchwald J., and Wolf J. Epithelial thymic tumors - therapy and prognosis. Thorac Cardiovasc Surg 36 (1988) 109-113
74. Utsumi T., Hiroyuki S., Matsumara A., Maeda H., Ohta M., Tada H., Akashi A., and Okumura M. Stage III thymoma: relationship of local invasion to recurrence. J Thorac Cardiovasc Surg 136 (2008) 1481-1485
75. Ciccone A.M., and Rendina E.A. Treatment of recurrent thymic tumors. Semin Thorac Cardivasc Surg 17 (2005) 27-31
76. Rea F., Marulli G., Girardi R., Bortolotti L., Favaretto A., Galligioni A., and Sartori F. Long term survival and prognostic factors in thymic epithelial tumors. Eur J Cardiothorac Surg 26 (2004) 412-418
77. Crucitti F., Doglietto G.B., Bellantone R., Perri V., Tommasini O., and Tonali P. Effects of surgical treatment in thymoma with myasthenia gravis: our experience with 103 patients. J Surg Oncol 50 (1992) 43-46
78. Wilkins E.J., Grillo H.C., Scannell J.G., Moncure A.C., and Mathisen D.J. Role of staging in prognosis and management of thymoma. Ann Thorac Surg 51 (1991) 888-892
79. Detterbeck F.C., and Parsons A.D. Thymic tumors: a review of current diagnosis, classification, and treatment. Pearson's thoracic and esophageal surgery. 3rd edition (2008), Churchill Livingstone-Elsevier 1589-1614
80. Uematsu M., and Kondo M. A proposal for treatment of invasive thymoma. Cancer 58 (1986) 1979-1984
81. Ariaratnam L.S., Kalmiki S., Mincer F., and Botsein C. The management of malignant thymoma with radiation therapy. Int J Radiat Oncol Biol Phys 5 (1979) 77-80
82. Arrigada R., Marchant-Gerard R., Tribiana M., Amiel J.L., and Haj L. Radiation therapy in the management of thymic tumors. Acta Radiol Oncol 20 (1981) 167-172
83. Singhal S., Shrager J.B., Rosenthal D.I., Li Volsi V.A., and Kaiser L.R. Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg 76 (2003) 1635-1642
84. Cheng Y.J. Videothoracoscopic resection of encapsulated thymic carcinoma: retrospective comparison of the results between thoracoscopy and open methods. Ann Surg Oncol 15 (2008) 2235-2238
85. Cheng Y.J., Hsu J.S., and Kao E.L. Characteristics of thymoma successfully resected by videothoracoscopic surgery. Surg Today 37 (2007) 192-196
86. Saviett M.A., Gao G., Furnary A.P., Swanson J., Gately H.L., and Handy J.R. Application of robotic-assisted techniques to the surgical evaluation and treatment of the anterior mediastinum. Ann Thorac Surg 79 (2005) 450-455
87. Bodner J., Wykypiel H., Greiner A., Kirchmayr W., Freund M.C., Margreiter R., and Schmid T. Early experience with robot assisted surgery for mediastinal masses. Ann Thorac Surg 78 (2004) 259-265
88. Haniuda M., Miyazawa M., Yoshida K., Oguchi M., Sakai F., Izuno I., and Sone S. Is postoperative radiotherapy for thymic carcinoma effective?. Ann Surg 224 (1996) 219-224
89. Akaogi E., Ohara K., Mitsui K., Onizuka M., Ishikawa S., Mitsui T., and Ogata T. Preoperative radiotherapy and surgery for advanced thymoma with invasion of the great vessels. J Surg Oncol 63 (1996) 17-22
90. Urgesi A., Monetti U., Rossi G., Ricardi U., Maggi G., and Sannazzari G.L. Aggressive treatment of intrathoracic recurrences in thymoma. Radiother Oncol 24 (1992) 221-225
91. Truong L.D., Mody D.R., and Cagle P.T. Thymic carcinoma: a clinicopathologic study of 13 cases. Am J Surg Pathol 14 (1990) 151-166
92. Dartevelle P., Macchiarini P., and Chapelier A. Technique of superior vena cava resection and reconstruction. Chest Surg Clin N Am 5 (1995) 345-358
93. De Giacomo T., Mazzesi G., Venuta F., and Coloni G.F. Extended operation for recurrent thymic carcinoma with intracaval growth and intracardiac extension. J Thorac Cardiovasc Surg 134 (2007) 1364-1365
94. Yagi K., Hirata T., Fukuse T., Yokomise H., Inui K., Ike O., Mizuno H., Aoki M., Hitomi S., and Wada H. Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded. Ann Thorac Surg 61 (1996) 521-544
95. Thomas C.R., Wright C.D., and Loherer J. Thymoma: state of the art. J. Clin Oncol 17 (1999) 2280-2289
96. Wright C.D. Pleuropneumonectomy for the treatment of Masaoka stage IVA thymoma. Ann Thorac Surg 82 (2006) 1234-1239
97. Huang J., Rizk N.P., Travis W.D., Seshan V.E., Bains M.S., Dycoco J., Downey R.J., Flores R.M., Park B.J., and Rush V. Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J Thorac Cardiovasc Surg 134 (2007) 1477-1484
98. Ruffini E., Filosso P.G., and Oliaro A. The role of surgery in recurrent thymic tumors. Thorac Surg Clin 19 (2009) 121-132
99. Regnard J.F., Zinzindohoue F., Magdeleinat P., Guibert L., Spaggiari L., and Levasseur P. Results of resection of recurrent thymomas. Ann Thorac Surg 64 (1997) 1593-1598
100. Kirschner P.A. Reoperation for thymoma: report of 23 cases. Ann Thorac Surg 49 (1990) 550-554
101. Boston B. Chemotherapy of invasive thymoma. Cancer 38 (1976) 49-52
102. Giaccone G. Treatment of malignant thymoma. Curr Opin Oncol 17 (2005) 140-146
103. Loehrer P.J., Kim K.M., Aisner S.C., Livingstone R., Einhorn L.H., Johnson D., and Blum R. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. J Clin Oncol 12 (1994) 1164-1168
104. Loehrer Sr. P.J., Chen M., Kim K., Aisner S.C., Einhorn L.H., Livingston R., and Johnson D. Cisplatin, doxorubicin and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol 15 (1997) 3093-3099
105. Hu E., and Levine J. Chemotherapy of malignant thymoma: case report and review of the literature. Cancer 57 (1986) 1101-1104
106. Godel N., Boning L., Fredrick A., Halzel D., Hartenstein R., and Wilmenns W. Chemotherapy of invasive thymoma: a retrospective study of 22 cases. Cancer 63 (1989) 1493-1500
107. Butler W.M., Diehl L.F., Taylor H.G., and Welz M.D. Metastatic thymoma with myasthenia gravis. Complete remission with combination chemotherapy. Cancer 50 (1982) 419-422
108. Kosmidis P.A., Iliopulos E., and Penetea S. Combination chemotherapy with cyclophosphamide, adriamycin and vincristine in malignant thymoma and myasthenia gravis. Cancer 61 (1988) 1736-1740
109. Dangaard G., Hansen H.H., and Roth M. Combination chemotherapy for malignant thymoma. Ann Intern Med 99 (1983) 189-190
110. Hernandez-Ilizaliturri F.J., Tan D., Cipolla D., Connoly G., Debb G., and Ramnath N. Multimodality therapy for thymic carcinoma (TCA): results of a 30 year single institution experience. Am J Clin Oncol 27 (2004) 68-72
111. Chalabreysse L., Etienne-Mastroianni B., Adeleine P., Cordier J.F., Greenland T., and Thivolet-Bejui F. Thymic carcinoma: a clinicopathological and immunohistological study of 19 cases. Histopathology 44 (2004) 367-374
112. de Bree E., van Ruth S., Baas P., Rutgers E.J., van Zandwijk N., Witkamp A.J., and Zoetmulder F.A. Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma. Chest 121 (2002) 1480-1487
113. Fornasiero A., Daniele O., Ghiotto C., Piazza M., Fiore-Donati L., Calabrò F., Rea F., and Fiorentino M.V. Chemotherapy for invasive thymoma: a 13 year experience. Cancer 68 (1991) 30-33
114. Loehrer P.J., Wang W., Johnson D.H., and Ettinger D.S. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group phase II trial. J Clin Oncol 15 (2004) 293-299
115. Yano T., Hara N., Ichinose Y., Asoh H., Yokoyama H., and Ohta M. Treatment and prognosis of primary thymic carcinoma. J Surg Oncol 52 (1993) 255-258
116. Weide L.G., Ulbright T.M., Loehrer P.J., and Williams S.D. Thymic carcinoma: a distinct clinical entity responsive to chemotherapy. Cancer 71 (1993) 1219-1223
117. Carlson R.W., Dorfman R.F., and Sikic B.I. Successful treatment of metastatic thymic carcinoma with cisplatin, vinblastin, bleomycin and etoposide chemotherapy. Cancer 66 (1990) 2092-2094
118. Ohara K., Tatsuraki H., Fuji H., Sugahara S., Okumura T., Akaogi E., Onizuka M., Ishikawa S., Mitsui K., and Itai Y. Radioresponse of thymomas verified with histologic response. Acta Oncol 37 (1998) 471-474
119. Mc Cart J.A., Gaspar L., Inculet R., and Casson AG. Predictors of survival following surgical resection of thymoma. J Surg Oncol 54 (1993) 233
120. Pollack A., Komaki R., Cox J.C., Ro J.Y., Oswald M.J., Shin D.M., and Putnam Jr. J.B. Thymoma: treatment and prognosis. Int J Radiat Oncol Biol Phys 23 (1992) 1037-1043
121. Haniuda M., Morimoto M., Nishimura H., Kobayashi O., Yamenda T., and Lida F. Adjuvant radiotherapy after complete resection of thymoma. Ann Thorac Surg 54 (1992) 311-315
122. Urgesi A., Monetti U., Rossi G., Ricardi U., and Casadio C. Role of radiation therapy in locally advanced thymoma. Radiother Oncol 19 (1990) 273-280
123. Koh W.J., Loehrer Sr. P.J., and Thomas Jr. C.R. Thymoma: the role of radiation and chemotherapy. In: Wood D.E., and Thomas C.R. (Eds). Mediastinal tumors: update 1005, Medical radiology - diagnostic imaging and radiation oncology volume (1995), Springer-Verlag, Heidelberg, Germany 19-25
124. Arakawa A., Yesunga T., Saitoh H., Uozumi H., Takada C., Baba Y., Yoshizumi K., and Takahashi M. Radiation therapy of invasive thymoma. Int J Radiat Oncol Biol Phys 18 (1990) 529-534
125. Shin D.M., Walsh G.L., Kornaki R., Putnam J.B., Nesbitt J., Ro J.Y., Shin H.J., Ki K.H., Wimberly A., Pisters K.M., Schrump D., Gregurich M.A., Cox J.D., Roth J.A., and Hong W.K. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Int Med 204 (1998) 859-864
126. Latz D., Schraube P., Oppitz U., Kugler C., Manegold C., Flentje M., and Wannenmacher M.F. Invasive thymoma: treatment with postoperative radiation therapy. Radiology 204 (1997) 859-864
127. Mornex F., Rosbeut M., Richaud P., Jung G.M., Mirabel X., Marchal C., Lagrange J.L., Rambert P., Chaplain G., and Nguyen T.D. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. Int Radiat Oncol Biol Phys 32 (1995) 651-659
128. Ciernik I.F., Meier U., and Lutolf V.M. Prognostic factors and outcome of incompletely resected invasive thymoma following radiation therapy. J Clin Oncol 12 (1994) 1484-1490
129. Kundel J., Yellin A., Popovitzer A., Pfeffer R., Symon Z., Simansky D.A., Oberman B., Sadezky S., Brenner B., Catane R., and Levitt M.L. Adjuvant radiotherapy for thymic epithelial tumors. Treatment results and prognostic factors. Am J Clin Oncol 30 (2007) 389-394
130. Uematsu M., Yoshida H., Kondo M., Itami J., Datano K., Isobe K., Ito H., Kobayashi K., Yamaguchi Y., and Kubo A. Entire hemithorax irradiation following complete resection in patients with stage II-III invasive thymoma. Int J Radiat Oncol Biol Phys 35 (1996) 357-360
131. Ichinose Y., Ohta M., Yano T., Yokoyama H., Asoh H., and Hata K. Treatment of invasive thymoma with pleural dissemination. J Surg Oncol 54 (1993) 180-183
132. Batata M.A., Martini N., Huvos A.G., Aguilar R.J., and Beattie E.J. Thymomas: clinicopathological features, therapy and prognosis. Cancer 34 (1974) 389-396
133. Ohara K., Okumura T., Sugahara S., Akisara M., Yokose T., Ogata T., Mitsui K., and Hasegawa S. The role of preoperative radiotherapy for invasive thymoma. Acta Oncol 29 (1990) 425-429
134. Sellors T.H., Thackray A.C., and Thomson A.D. Tumors of the thymus: a review of 88 operated cases. Thorax 22 (1967) 193-220
135. Rea F., Sartori F., Loy M., Calabrò F., Fornasiero A., Danile O., and Altavilla G. Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg 106 (1993) 543-549
136. Lucchi M., Ambrogi M.C., Duranti L., Basolo F., Fontanini G., Angeletti C.A., and Mussi A. Advanced stage thymomas and thymic carcinomas: results of multimodality treatment. Ann Thorac Surg 79 (2005) 1840-1844
137. Macchiarini P., Chella A., Ducci F., Rossi B., Testi C., Bevilacqua G., and Angeletti C.A. Neoadjuvant chemotherapy, surgery and postoperative radiation therapy for invasive thymoma. Cancer 68 (1991) 706-713
138. Ribet M., Voisin C., Pruvot F.R., Ramon P., and Dambron P. Lympho-epithelial thymomas: a retrospective study of 88 resections. Eur J Cardiothorac Surg 2 (1988) 261-264
139. Gewrychowski J., Rockicki M., Gabriel A., Lackwoska B., and Czyzewiski D. Thymoma - the usefulness of some prognostic factors for diagnosis and surgical treatment. Eur J Surg Oncol 26 (2000) 203-208
140. Kim E.S., Putnam J.B., Komaki R., Walsh G.L., Ro J.Y., Shin H.J., Truong M., Moon H., Swisher S.G., Fossella F.V., Khuri F.R., Hong W.K., and Shin D.M. Phase II study of a multidisciplinary approach with induction chemotherapy followed by surgical resection, radiation therapy and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 44 (2004) 369-379
141. Wright C.D., Choi N.C., Wain J.C., Mathisen D.J., Lynch T.J., and Fidias P. Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors. Ann Thorac Surg 85 (2008) 385-389
142. Blackburn C.C., and Manley N.R. Developing a new paradigm for thymus organogenesis. Nat Rev Immunol 4 (2004) 278-289
143. Chen Z., Zhang X., Li M., Wang Z., Wieand H.S., Grandis J.R., and Shin D.M. Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase - 2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck. Clin Cancer Res 10 (2004) 5930-5939
144. Hanley J.D., Koukolis G.H., and Loehrer Sr. P.J. Epidermal growth factor expression in invasive thymoma. J Cancer Res Clin Oncol 128 (2002) 167-170
145. Palmieri G., Marino M., Salvatore M., Budillon A., Meo G., Caraglia M., and Montella L. Cetuximab is an active treatment of metastatic and chemorefractory thymoma. Front Biosci 12 (2007) 167-170
146. Yamaguchi H., Sada H., Kitezoki T., Tsukamoto K., Hayashi T., and Kohno S. Thymic carcinoma with epidermal growth factor receptor gene mutations. Lung Cancer 52 (2006) 261-262
147. Henley J.D., Cummings O.W., and Loehrer Sr. P.J. Tyrosine kinase receptor expression in thymomas. J Cancer Res Oncol 130 (2004) 222-224
148. Pan C.C., Chen P.C.H., and Chiang H. KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas. J Pathol 202 (2004) 375-381
149. Nakagawa K., Matsuno Y., Kumitoh H., Maeshima A., Asamura H., and Tsuchia R. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors. Chest 128 (2005) 140-144
150. Strobel P., Hartman M., Jakob A., Mikesch K., Brink I., Dirnhofer S., and Marx A. Thymic carcinoma with overexpression of mutated KIT and the response to Imatinib. New Engl J Med 350 (2004) 2625-2626
151. Rickter R.J., Joos S., Mechtersheimer G., Blaeker H., Schnabel P.A., Morresi-Hauf A., Hecker E., Thomas M., Dienemann H., Schirmacher P., and Kern M.A. COX-2 upregulation in thymomas and thymic carcinomas. Int J Cancer 119 (2006) 2063-2070
152. Sasaki H., Fukai I., Kiriyama M., Jaji M., Yano M., Yamakawa Y., and Fuji Y. Thymidilate synthase and dihydropyrimidine dehydrogenase mRNA levels in thymoma. Surg Today 33 (2003) 83-88